Sagimet Biosciences (SGMT) Institutional Ownership $7.34 -0.02 (-0.27%) Closing price 09/3/2025 04:00 PM EasternExtended Trading$7.18 -0.16 (-2.18%) As of 09/3/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Sagimet Biosciences (NASDAQ:SGMT)CurrentInstitutional OwnershipPercentage87.86%Number ofInstitutional Buyers(last 12 months)29TotalInstitutional Inflows(last 12 months)$9.56MNumber ofInstitutional Sellers(last 12 months)18TotalInstitutional Outflows(last 12 months)$12.40M Get SGMT Insider Trade Alerts Want to know when executives and insiders are buying or selling Sagimet Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data SGMT Institutional Buying and Selling by Quarter Sagimet Biosciences Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/15/2025 BNP Paribas Financial Markets26,785$204K0.0%+9,168.2%0.087% 8/15/2025 Bridgeway Capital Management LLC412,841$3.15M0.1%+231.6%1.346% 8/15/2025 Bank of America Corp DE9,943$76K0.0%+81.8%0.032% 8/14/2025 Raymond James Financial Inc.264,675$2.02M0.0%-23.5%0.863% 8/13/2025 Jump Financial LLC148,351$1.13M0.0%N/A0.484% 8/12/2025 XTX Topco Ltd25,624$195K0.0%+137.0%0.084% 8/12/2025 American Century Companies Inc.42,285$322K0.0%+8.9%0.138% 8/8/2025 Bailard Inc.29,029$221K0.0%N/A0.095% 8/8/2025 Geode Capital Management LLC265,324$2.02M0.0%+0.6%0.865% 8/5/2025 ANTIPODES PARTNERS Ltd5,412$41K0.0%N/A0.018% Get the Latest News and Ratings for SGMT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Sagimet Biosciences and its competitors with MarketBeat's FREE daily newsletter. 8/4/2025 Dumac Inc.75,000$572K3.6%-49.1%0.244% 7/30/2025 FNY Investment Advisers LLC86,744$660K0.3%-52.2%0.283% 7/21/2025 Abacus Planning Group Inc.29,968$228K0.0%+14.6%0.098% 7/16/2025 ORG Wealth Partners LLC17,791$143K0.0%N/A0.058% 6/27/2025 Goldman Sachs Group Inc.23,603$77K0.0%-82.3%0.077% 5/16/2025 Goldman Sachs Group Inc.23,603$77K0.0%-82.3%0.077% 5/16/2025 NewEdge Advisors LLC32,290$105K0.0%N/A0.105% 5/16/2025 Alyeska Investment Group L.P.1,192,443$3.89M0.0%-7.6%3.887% 5/15/2025 Trexquant Investment LP26,132$85K0.0%N/A0.085% 5/15/2025 OMERS ADMINISTRATION Corp85,600$279K0.0%+46.3%0.279% 5/14/2025 Pale Fire Capital SE10,989$36K0.0%-40.0%0.036% 5/14/2025 Jasper Ridge Partners L.P.19,000$62K0.0%N/A0.062% 5/13/2025 American Century Companies Inc.38,831$127K0.0%+93.2%0.127% 5/13/2025 Persistent Asset Partners Ltd10,597$35K0.0%N/A0.035% 5/9/2025 Charles Schwab Investment Management Inc.15,000$49K0.0%N/A0.049% 5/8/2025 XTX Topco Ltd10,811$35K0.0%N/A0.035% 4/14/2025 Abacus Planning Group Inc.26,149$85K0.0%N/A0.085% 2/17/2025 Squarepoint Ops LLC50,484$227K0.0%+72.4%0.165% 2/17/2025 Two Sigma Investments LP50,433$227K0.0%-72.5%0.164% 2/17/2025 Shay Capital LLC19,332$87K0.0%N/A0.063% 2/17/2025 OMERS ADMINISTRATION Corp58,500$263K0.0%N/A0.191% 2/17/2025 Millennium Management LLC693,247$3.12M0.0%+257.1%2.260% 2/17/2025 Dumac Inc.163,514$736K1.1%-13.7%0.533% 2/17/2025 Bridgeway Capital Management LLC224,100$1.01M0.0%+62.0%0.731% 2/17/2025 Baker BROS. Advisors LP952,996$4.29M0.0%-31.0%3.107% 2/17/2025 Bank of America Corp DE15,043$68K0.0%-97.2%0.049% 2/17/2025 Alyeska Investment Group L.P.1,290,512$5.81M0.0%-6.4%4.208% 2/17/2025 683 Capital Management LLC138,263$622K0.0%N/A0.451% 2/14/2025 Jane Street Group LLC55,274$249K0.0%N/A0.180% 2/14/2025 Schonfeld Strategic Advisors LLC39,452$178K0.0%-63.3%0.129% Elon’s Secret Social Security Bombshell (Ad)To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social Security? What we just discovered in Washington will stun even the most seasoned insiders.A major government announcement coming as soon as tomorrow.2/14/2025 Boothbay Fund Management LLC12,518$56K0.0%-89.1%0.041% 2/14/2025 Blue Owl Capital Holdings LP1,323,877$5.96M1.4%-20.9%4.317% 2/14/2025 Dimensional Fund Advisors LP25,334$114K0.0%N/A0.083% 2/13/2025 Marshall Wace LLP203,782$917K0.0%-22.7%0.664% 2/13/2025Summit Financial Wealth Advisors LLC13,000$61K0.0%N/A0.042% 2/13/2025 Renaissance Technologies LLC10,800$49K0.0%-95.3%0.035% 2/13/2025 Wells Fargo & Company MN6,810$31K0.0%N/A0.022% 2/12/2025 Geode Capital Management LLC255,236$1.15M0.0%+1.2%0.832% 2/12/2025 JPMorgan Chase & Co.48,064$216K0.0%-33.3%0.157% 2/11/2025 American Century Companies Inc.20,103$90K0.0%N/A0.066% 2/11/2025 Virtu Financial LLC25,043$113K0.0%-26.7%0.082% 1/28/2025 Stoneridge Investment Partners LLC20,836$94K0.0%+22.2%0.068% 1/21/2025 Jacksonville Wealth Management LLC10,000$45K0.0%N/A0.033% 1/13/2025 FNY Investment Advisers LLC130,250$586K0.3%-12.0%0.425% 1/10/2025 ORG Wealth Partners LLC21,448$97K0.0%-50.0%0.070% 12/26/2024 JPMorgan Chase & Co.72,017$199K0.0%+66.2%0.235% 11/20/2024 Virtu Financial LLC34,166$95K0.0%-34.1%0.111% 11/19/2024 Barclays PLC57,230$159K0.0%+14.3%0.187% 11/16/2024 Geode Capital Management LLC252,298$699K0.0%+56.7%0.823% 11/15/2024 Barclays PLC57,230$159K0.0%+14.3%0.187% 11/15/2024 Ikarian Capital LLC387,565$1.07M0.1%-6.1%1.264% 10/11/2024 ORG Wealth Partners LLC42,896$119K0.0%N/A0.140% 8/19/2024 Point72 Asset Management L.P.2,366,090$8.09M0.0%-11.3%7.786% 8/14/2024 Squarepoint Ops LLC94,740$324K0.0%N/A0.312% 8/12/2024 XTX Topco Ltd41,548$142K0.0%-29.8%0.137% 8/9/2024 Renaissance Technologies LLC242,400$829K0.0%-42.2%0.798% 8/8/2024 Federated Hermes Inc.68,000$233K0.0%+25.9%0.224% 8/8/2024 Ground Swell Capital LLC22,687$78K0.1%N/A0.075% 8/6/2024 Acadian Asset Management LLC68,451$232K0.0%+96.0%0.225% 8/5/2024 Victory Capital Management Inc.77,420$265K0.0%+49.1%0.255% 7/29/2024 Nations Financial Group Inc. IA ADV15,000$51K0.0%N/A0.049% 7/16/2024 ORG Partners LLC13,611$43K0.0%N/A0.045% 6/4/2024 DekaBank Deutsche Girozentrale20,000$113K0.0%N/A0.066% 5/17/2024 Artal Group S.A.724,771$3.93M0.1%-21.6%2.271% 5/17/2024 Ikarian Capital LLC412,565$2.24M0.2%N/A1.293% 5/15/2024 Baker BROS. Advisors LP1,381,898$7.49M0.1%-5.1%4.331% 5/15/2024 NEA Management Company LLC2,000,275$10.84M0.7%-48.0%6.268% 5/15/2024 Price T Rowe Associates Inc. MD16,705$91K0.0%N/A0.052% 5/15/2024 Hhlr Advisors LTD.724,800$3.93M0.1%-50.0%2.271% 5/14/2024 Platinum Investment Management Ltd.90,633$491K0.0%-18.9%0.284% 5/14/2024 American International Group Inc.11,372$62K0.0%+312.0%0.036% 5/13/2024 O Shaughnessy Asset Management LLC13,344$72K0.0%N/A0.042% 5/10/2024 Acadian Asset Management LLC34,929$188K0.0%N/A0.109% 5/10/2024 Vanguard Group Inc.1,139,407$6.18M0.0%+364.9%3.570% 2/14/2024 Platinum Investment Management Ltd.111,752$606K0.0%-70.9%0.523% 2/5/2024 Victory Capital Management Inc.56,570$307K0.0%+215.0%0.265% 1/31/2024 Federated Hermes Inc.97,276$527K0.0%+24.7%0.455% 11/15/2023 RTW Investments LP400,277$3.52M0.1%N/A1.875% 11/15/2023 Rock Springs Capital Management LP738,355$6.50M0.2%N/A3.458% 11/14/2023 Dumac Inc.204,123$1.80M4.8%N/A0.956% Google did what!?!? (Ad)A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bill Gates has backed four companies in this space. The World Economic Forum calls it “the most exciting human discovery since fire.” Whitney Tilson believes this trend could mint a new class of wealthy investors—and he’s sharing one stock to watch now, for free.Gates and Altman are betting big—see why11/13/2023CHI Advisors LLC348,842$3.07M0.9%N/A1.634% 11/13/2023 Federated Hermes Inc.78,000$686K0.0%N/A0.365% 11/13/2023 Silverarc Capital Management LLC100,000$880K0.3%N/A0.468% 11/13/2023 FMR LLC2,672,355$23.52M0.0%N/A12.517% 11/7/2023 New York State Common Retirement Fund6,357$56K0.0%N/A0.030% 11/6/2023 Victory Capital Management Inc.17,960$158K0.0%N/A0.084% 11/3/2023 Platinum Investment Management Ltd.383,913$3.38M0.1%N/A1.798% 10/31/2023 Teacher Retirement System of Texas25,000$220K0.0%N/A0.117% (Data available from 1/1/2016 forward) SGMT Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of SGMT shares? During the previous two years, 67 institutional investors and hedge funds held shares of Sagimet Biosciences. The most heavily invested institutionals were FMR LLC ($23.52M), NEA Management Company LLC ($10.84M), Point72 Asset Management L.P. ($8.09M), Rock Springs Capital Management LP ($6.50M), Vanguard Group Inc. ($6.18M), Blue Owl Capital Holdings LP ($5.96M), and Baker BROS. Advisors LP ($4.29M).Learn more on Sagimet Biosciences' institutional investors. What percentage of Sagimet Biosciences' stock is owned by institutional investors? 87.86% of Sagimet Biosciences' stock is owned by institutional investors. Learn more on SGMT's institutional investor holdings. Which institutional investors have been buying Sagimet Biosciences' stock? Of the 50 institutional investors that purchased Sagimet Biosciences' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: FMR LLC ($2.67M), Vanguard Group Inc. ($894.32K), Rock Springs Capital Management LP ($738.36K), Millennium Management LLC ($499.09K), Ikarian Capital LLC ($412.57K), RTW Investments LP ($400.28K), and Platinum Investment Management Ltd. ($383.91K). How much institutional buying is happening at Sagimet Biosciences? Institutional investors have bought a total of 1,865,997 shares in the last 24 months. This purchase volume represents approximately $9.56M in transactions. Which of Sagimet Biosciences' major shareholders have been selling company stock? Of the 18 institutional investors that sold Sagimet Biosciences' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Bank of America Corp DE ($525.39K), Baker BROS. Advisors LP ($428.90K), Blue Owl Capital Holdings LP ($350K), Renaissance Technologies LLC ($220.30K), Goldman Sachs Group Inc. ($218.93K), Alyeska Investment Group L.P. ($185.92K), and Two Sigma Investments LP ($133.21K). How much institutional selling is happening at Sagimet Biosciences? Institutional investors have sold a total of 2,689,581 shares in the last 24 months. This volume of shares sold represents approximately $12.40M in transactions. Related Companies Praxis Precision Medicines Institutional Ownership Upstream Bio Institutional Ownership Urogen Pharma Institutional Ownership uniQure Institutional Ownership Trevi Therapeutics Institutional Ownership Phathom Pharmaceuticals Institutional Ownership Amylyx Pharmaceuticals Institutional Ownership Akebia Therapeutics Institutional Ownership Anavex Life Sciences Institutional Ownership Immunome Institutional Ownership This page (NASDAQ:SGMT) was last updated on 9/4/2025 by MarketBeat.com Staff From Our PartnersCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredWhat's the Best Way to Lower RMD Taxes?Turning 73 triggers a key IRS rule: you must begin taking required minimum distributions (RMDs) from certain r...SmartAsset | SponsoredNVIDIA's Worst Nightmare?$2 TRILLION Quantum Gold Rush While everyone fights over expensive AI stocks... McKinsey just revealed the ...The Oxford Club | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredFree: The Crypto Summit That Could Change Your Life27 industry leaders share urgent market intel (free access)... For a very limited time, you can claim your ...Crypto 101 Media | SponsoredThis Massive Market is Ripe for Disruption by this NasdaqFanatics Hit $31B. This Nasdaq Company Is Building the Next Wave Fanatics built a merch empire by owning th...i2i Marketing Group, LLC | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sagimet Biosciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sagimet Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
